1. Home
  2. Analysis
  3. Fintepla
  4. Briviact

Fintepla and Briviact drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fintepla (fenfluramine hydrochloride) and Briviact (brivaracetam). Common drug interactions include hospitalisation among females and seizure among males.

The phase IV clinical study analyzes what interactions people have when they take Fintepla and Briviact. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Fintepla?

Fintepla has active ingredients of fenfluramine hydrochloride. eHealthMe is studying from 2,613 Fintepla users. Check the latest studies of Fintepla.

What is Briviact?

Briviact has active ingredients of brivaracetam. It is often used in epilepsy. eHealthMe is studying from 3,433 Briviact users. Check the latest studies of Briviact.

On Jul, 30, 2026

52 people who take Fintepla and Briviact together, and have interactions are studied.

Fintepla and Briviact drug interactions.

What are the common drug interactions of Fintepla and Briviact, by gender? *:

female:

  1. Hospitalisation
  2. Hyperhidrosis (abnormally increased sweating)
  3. Influenza
  4. Infusion related reaction
  5. Pneumonia
  6. Rash
  7. Sinusitis (inflammation of sinus)
  8. Skin irritation
  9. Urinary tract infection
  10. Abdominal discomfort

male:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Diarrhoea
  4. Weight decreased
  5. Dehydration (dryness resulting from the removal of water)
  6. Sedation
  7. Vomiting
  8. Abdominal discomfort
  9. Aortic valve incompetence
  10. Decreased appetite

What are the common drug interactions of Fintepla and Briviact, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Drug ineffective
  2. Gait disturbance
  3. Insomnia (sleeplessness)
  4. Seizure cluster (small group of seizure)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Weight decreased
  7. Lip swelling
  8. Swollen tongue (swelling of tongue)
  9. Therapeutic response unexpected
  10. Throat irritation

10-19:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Drug ineffective
  4. Fatigue (feeling of tiredness)
  5. Insomnia (sleeplessness)
  6. Hypersomnia (excessive daytime sleepiness (eds))
  7. Ear infection
  8. Nausea (feeling of having an urge to vomit)
  9. Viral infection
  10. Abdominal discomfort

20-29:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Aortic valve incompetence
  3. Head injury
  4. Tricuspid valve incompetence (inefficient heart valve)
  5. Atonic seizures (minor type of seizure)
  6. Decreased appetite
  7. Fall
  8. Fluid intake reduced
  9. Lennox-gastaut syndrome (epilepsy characterized by frequent seizures and different seizure types)
  10. Lethargy (tiredness)

30-39:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Hypersomnia (excessive daytime sleepiness (eds))
  3. Diarrhoea
  4. Weight increased
  5. Anger
  6. Back pain
  7. Dry skin
  8. Hallucination, auditory (perceiving sounds without auditory stimulus)
  9. Pericardial effusion (fluid around the heart)
  10. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)

40-49:

  1. Diarrhoea
  2. Fall
  3. Foot fracture
  4. Hand fracture
  5. Muscular weakness (muscle weakness)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Thyroid disorder (thyroid diseases)
  9. Aortic valve incompetence
  10. Atrophy (wasting away of a part of the body)

50-59:

  1. Abnormal behaviour
  2. Hallucinations, mixed (sensations that appear real but are created by your mind -mixed)

60+:

  1. Aortic valve incompetence
  2. Left ventricular dysfunction
  3. Mitral valve incompetence (inefficient heart valve)
  4. Pulmonary valve incompetence
  5. Tricuspid valve incompetence (inefficient heart valve)

What are the existing conditions these people have? *

  1. Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 20 people, 38.46%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 14 people, 26.92%

* Approximation only. Some reports may have incomplete information.

Do you take Fintepla and Briviact?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fintepla and Briviact:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fintepla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Briviact:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fintepla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Briviact and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fenfluramine hydrochloride and brivaracetam (the active ingredients of Fintepla and Briviact, respectively), and Fintepla and Briviact (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.